Centessa Pharmaceuticals plc - ADR
CNTA
Market Cap$1.75B
Close$
$2.32
83.5% downside
Current Fair Value
83.5% downsideOvervalued by 83.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.75 Billion |
|---|---|
| Enterprise Value | $1.66 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.06 |
| Beta | 1.49 |
| Outstanding Shares | 133,034,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -7.8 |
|---|---|
| PEG | 24.95 |
| Price to Sales | - |
| Price to Book Ratio | 7.04 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -7.29 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Centessa Pharmaceuticals plc
2,021 employees